Date: Mar 12, 2015 Author: Brian Gormley Source: dowjones.com (
click here to go to the source)
PhaseBio Pharmaceuticals Inc . has raised $40 million to develop drugs for two of the largest markets in health care: Type 2 diabetes and heart failure.
Type 2 diabetes affects about 28 million Americans, according to the American Diabetes Association . More than five million Americans have heart failure, according to the Centers for Disease Control and Prevention ....
